Compare PTCT & MTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | MTRN |
|---|---|---|
| Founded | 1998 | 1931 |
| Country | United States | United States |
| Employees | N/A | 2880 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.1B |
| IPO Year | 2006 | 2000 |
| Metric | PTCT | MTRN |
|---|---|---|
| Price | $75.18 | $247.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 4 |
| Target Price | ★ $80.65 | $52.50 |
| AVG Volume (30 Days) | ★ 1.0M | 259.0K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.32% |
| EPS Growth | 264.48 | ★ 1178.57 |
| EPS | N/A | ★ 0.92 |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $15.31 |
| Revenue Next Year | $17.70 | $7.57 |
| P/E Ratio | ★ N/A | $267.39 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $43.18 | $76.09 |
| 52 Week High | $87.50 | $247.03 |
| Indicator | PTCT | MTRN |
|---|---|---|
| Relative Strength Index (RSI) | 60.42 | 71.67 |
| Support Level | $73.41 | $116.88 |
| Resistance Level | $79.67 | N/A |
| Average True Range (ATR) | 2.59 | 10.02 |
| MACD | 0.43 | 0.90 |
| Stochastic Oscillator | 90.99 | 77.87 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Materion Corp offers products that include precious and non-precious specialty metals, inorganic chemicals and powders, specialty coatings, specialty engineered beryllium and copper-based alloys, beryllium composites, ceramics, and engineered clad and plated metal systems. Its segments are: Performance Materials provides beryllium and non-beryllium containing alloy systems and custom engineered parts. Electronic Materials produces chemicals, microelectronics packaging, and specialty metal products, including vapor deposition targets and preforms. Precision Optics produces thin film coatings and optical filter materials. The Other reportable segment includes unallocated corporate costs and assets. It operates in the United States, Asia, Europe, and other countries.